World Journal of
Pharmaceutical and Life Sciences

REVIEW ON CONTROL OF COVID-19 USING AN ANTIMALARIAL FIRST LINE DRUG

Vaishnavi S. Khemnar*

ABSTRACT

A novel human virus called coronavirus, SARS-CoV-2, or COVID-19, has become a pandemic disease. It was
started last week of November 2019 in Wuhan, a city in China. It causes severe respiratory tract infections and
other diseases. It is transmitted from human to human within incubation times between two to ten days. It is spread
via droplets, contaminated hands, or surfaces. Recently research concluded the new SARS-Cov-2 coronavirus.
Main body: More than 200 countries throughout the world have become suffered from malaria, and every year a
large number of people die by the cause of malaria. We observed that there was no significant effect of coronavirus,
SARS-CoV-2, or COVID-19 on malaria-affected countries. As per the recommendation given by World Health
Organization, Artemisinin and its derivatives like Dihydroartemisinin, Artemether, Arteether, and Artesunate are
used to kill parasites at an early phase of their development, quickly decreasing their numbers. Among all
derivatives, Artesunate has the activity against HIV virus, and HIV virus has some structural similarity with
coronavirus SARS-Cov-2 as both are RNA-based virus. There is a possibility for using Artesunate in malariainfected
countries; the coronavirus SARS-Cov-2 is unable to show a significant impact on malaria-affected
countries.

[Full Text Article]   [Download Certificate]